Oric Pharmaceuticals, Inc. Common Stock ORIC
$12.93
-4.01%
at last close
Market Cap$1.34 billion
P/E Ratio—
Div Yield—
Volume2.14M
52-Week Range
$7.23$14.93
Key Stats
- Today's Range
- $12.75 – $14.05
- 50-Day Range
- $7.32 – $14.05
- 52-Week Range
- $7.23 – $14.93
- Volume
- 2.14 million shs
- Average Volume
- 1.86 million shs
- Market Cap
- $1.34 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 3.52
- Price / Sales
- —
Short Interest
- Short Interest
- 0.65%
- Days to Cover
- 1.37
Financials (TTM)
- Revenue
- —
- Net Income
- $-140,351,000
- Net Margin
- —
- Return on Equity
- -36.81%
- Debt-to-Equity
- —
About Oric Pharmaceuticals, Inc. Common Stock
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Related Stocks
Compare head-to-head: ORIC vs LLY·ORIC vs JNJ·ORIC vs ABBV·ORIC vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.